{
    "nctId": "NCT01291082",
    "briefTitle": "Whole-body MR in Staging Bone and Soft Tissue Metastases in Breast Cancer Patients(MetaMaRBo)",
    "officialTitle": "Whole-body Magnetische Resonantie Voor Het Opsporen Van Bot- en Weke Delenmetastasen Bij pati\u00ebnten Met Een Borstcarcinoom (MetaMaRBo)",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Validation of whole body diffusion weighted MRI in breastcancer patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients with a proven breast cancer (by biopsy or imaging)\n2. Bone metastases proven by MR, PET-CT or Bone. Patients with visceral metastases can be included if bone metastases are also present.\n3. Patient with an informed consent.\n\nExclusion Criteria:\n\n1. Patients with a single bone metastasis treated by Radiotherapy will be excluded.\n2. Patients with contra-indication for MRI: pacemaker, cochlear implant, non MR compatible devices (Baclofenpump).\n3. Claustrophobia\n4. Patient in a bad general condition.",
    "sex": "ALL",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}